EXPRESS: Novel Dose-Response Analyses of Treprostinil in Pulmonary Arterial Hypertension and Its Effects on 6-Minute Walk Distance and Hospitalizations

Pulmonary Circulation - United States
doi 10.1177/2045894020923956
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Validation of 6-Minute Walk Distance as a Surrogate End Point in Pulmonary Arterial Hypertension Trials

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

What Can Be Learned in 6 Minutes? 6-Minute Walk Test Primer and Role in Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension
2010English

Alternatives to the Six-Minute Walk Test in Pulmonary Arterial Hypertension

PLoS ONE
Multidisciplinary
2014English

Automated 6-Minute Walk Test Distance Measurement and Walk Characterisation Using a Novel Infrared Sensor-Based Technique

Sains Malaysiana
Multidisciplinary
2019English

6 Minute Walk Test and Idiopathic Pulmonary Fibrosis: Distance or Desaturation? A Prospective Observational Study

Journal of Medicine and Therapeutics
2017English

Validation of the 6-Minute Walk in Patients With Pulmonary Arterial Hypertension: Trying to Fit a Square Peg Into a Round Hole?

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

Prs9 - Switching From Subcutaneous Treprostinil to Inhaled Treprostinil in Pulmonary Arterial Hypertension Treatment and Economic Impact Evaluation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

EXPRESS: Management of Prostacyclin Side Effects in Adult Patients With Pulmonary Arterial Hypertension

Pulmonary Circulation
PulmonaryRespiratory Medicine
2017English

Tolerability and Clinical Efficacy of Inhaled Treprostinil in Patients With Group 1 Pulmonary Arterial Hypertension

Therapeutic Advances in Chronic Disease
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy